Virbac invites you to their event

STELFONTAⓇ (tigilanol tiglate injection): Practical aspects, Case reports and Tips from veterinarians who are using it

About this event

Many of you have already experienced STELFONTAⓇ(tigilanol tiglate injection) on your own, while some of you remain curious to try STELFONTA. In this webinar, several of your colleagues will share their individual cases and experience with STELFONTA.

Please join us to learn more about this exciting option for mast cell tumor treatment in dogs!

This is a live event only and will not be recorded.

This program has been approved for 1.0 hour of continuing education credit in jurisdictions which recognize RACE approval. Virbac is approved as a NY State sponsor of continuing education for veterinarians and veterinary technicians. You must attend the full presentation to receive CE credit.

STELFONTA is an FDA approved, intratumoral injection indicated for use in dogs for the local treatment of: Non-metastatic cutaneous mast cell tumors anywhere on the body, Non-metastatic subcutaneous mast cell tumors located at or distal to, the elbow or hock

IMPORTANT SAFETY INFORMATION

Accidental self-injection of STELFONTA® (tigilanol tiglate injection) may cause severe wound formation. To decrease the risk of accidental self-injection, sedation of the dog may be necessary. In dogs, do not inject STELFONTA into subcutaneous mast cell tumors located above the elbow or hock. Formation of wounds, possibly extensive, is an intended and likely response to treatment with STELFONTA along with associated swelling, bruising and pain; these wounds are expected to heal. Some of these cases resulted in amputation. Appropriate pre- and post-treatment medications must be given, including a corticosteroid plus blocking agents for both H1 and H2 receptors, in order to decrease the potential for severe systemic adverse reactions, including death, from mast cell degranulation. For full prescribing information, contact VIRBAC at 1-800-338-3659 or visit https://vet-us.virbac.com/stelfonta.

Hosted by

  • Team member
    T
    Scott Weinman, DVM, MBA Senior Field Technical Services Veterinarian-West Coast @ Virbac Animal Health

    Dr. Weinman received his veterinary degree from Iowa State University's CVM. While in full-time veterinary practice, he completed an MBA in Operations Management from Seattle University. He also completed a one year fellowship in Shelter Medicine at UC Davis (ASPCA sponsored training).

  • Guest speaker
    JJ G
    Jerrod Johnson Partner, Managing DVM @ NVA Gateway Veterinary Management Group, LLC

    Dr. Jerrod Johnson received his Bachelor of Science in Biology from the University of the Cumberlands in 2007. In 2011, he graduated from Auburn University’s College of Veterinary Medicine and is currently a partner and managing DVM for NVA Gateway Veterinary Management Group, LLC. Dr. Johnson is a diplomate of the American Board of Veterinary Practice in canine and feline practice. He is certified in companion animal pain management and an active consultant in rehab, sports medicine, and chronic pain for VIN. Dr. Johnson is an Elite Fear-Free certified professional, a member of the International Veterinary Academy of Pain Management, and a member of the International Association for the Study of Pain.

Virbac

Shaping the Future of Animal Health